Nath Bio-Genes (India) Limited

BSE: 537291 NSE: NATHBIOGEN
Nath Bio-Genes (India) Limited - agriculture in Aurangabad, Maharashtra, India. FY 2026 financials and compliance.
CIN L01110MH1993PLC072842 Incorporated 14 July 1993 ROC Mumbai HQ Aurangabad, Maharashtra, India
Active Listed - NSE: NATHBIOGEN · BSE: 537291 Public Limited Company agriculture
Data last updated
Revenue · FY 2026
₹445.1 Cr
▲ 21.98% YoY
Computed EBITDA · FY 2026
₹60.25 Cr
▲ 10.87% YoY
Net profit · FY 2026
₹41.63 Cr
▲ 7.85% YoY
Authorised capital
₹21 Cr
Registered with MCA
Paid-up capital
₹19 Cr
Issued & subscribed
Open charges
₹114.1 Cr
Satisfied ₹183.2 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
417
Latest available

About Nath Bio-Genes (India) Limited

Data last updated: 14 July 2026

Nath Bio-Genes (India) Limited is a public limited company based in Aurangabad, Maharashtra, India. It specialises in seed production and distribution, a part of the broader agriculture sector. Incorporated on 14 July 1993, the company has been in operation for over 33 years.

Registered with ROC Mumbai under CIN L01110MH1993PLC072842. Listed on BSE: 537291 and NSE: NATHBIOGEN.

Capital: an authorised share capital of ₹21 Cr and a paid-up capital of ₹19 Cr. It is led by directors including Satish Laxminarayan Kagliwal and Madhukar Dhondiraj Deshpande.

Last AGM: 22 August 2025. Financial statements filed for year ended 31 March 2025. Office: Nath House Nath Road, Aurangabad, Maharashtra, India – 431005.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹445.1 Cr, a growth of 21.98% compared to the previous year. The net worth stands at ₹680.46 Cr (up 5.6% YoY). Total assets are valued at ₹1,097.42 Cr (up 6.94% YoY).

The company has a workforce of approximately 417 employees as per the latest available data.

The company is associated with 1 brand - Nath Bio-Genes. As per MCA filings, the company has open charges of ₹114.1 Cr and satisfied charges of ₹183.2 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nathbiogenes.com.

Company Details of Nath Bio-Genes (India) Limited
CIN L01110MH1993PLC072842
Registration Number 072842
Incorporation Date 14 July 1993
ROC Mumbai
Listing Status Listed (BSE: 537291, NSE: NATHBIOGEN)
Company Status Active
Date of Last AGM 22 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Satish Laxminarayan Kagliwal Managing Director Madhukar Dhondiraj Deshpande Director Jeevanlata Nandkishor Kagliwal Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    nathbiogenes.com
  • Social Media
  • Registered Address
    Nath House Nath Road, Aurangabad, Maharashtra, India – 431005
  • Industry
    Agriculture, Seed Production & Distribution
Company report
Nath Bio-Genes (India) Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Nath Bio-Genes (India) Limited report

Financials, compliance, directors, charges, ownership and filings for Nath Bio-Genes (India) Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited has one previous CIN (Corporate Identification Number): U01110MH1993PLC072842. The current CIN is L01110MH1993PLC072842, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L01110MH1993PLC072842 Current
U01110MH1993PLC072842 Previous

Associated Brands with Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited operates one associated brand: Nath Bio-Genes. These brands represent Nath Bio-Genes (India) Limited's diversified market presence and brand portfolio.

Brand Description Website
Nath Bio-Genes
Company that develops, produces, and markets hybrid and seeds for various crops, with a focus on improving crop yields nathbiogenes.com

Business Activity of Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited is engaged in the principal business activity of agriculture, forestry, fishing, with detailed activities including support activities to agriculture and other activities including hunting.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
A Agriculture, forestry, fishing A4 Support activities to agriculture and Other Activities including hunting Locked
Premium access

Business activity turnover details for Nath Bio-Genes (India) Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited is audited by GAUTAM N ASSOCIATES, CHARTERED ACCOUNTANTS (ICAI peer reviewed, certificate valid till 2027-06-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
GAUTAM N ASSOCIATES, CHARTERED ACCOUNTANTS (ICAI peer reviewed, certificate valid till 2027-06-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited is currently managed by 7 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Satish Laxminarayan Kagliwal
Also directs: Barkha Farms Llp, Agri-Tech (India) Limited, Nath Royal Limited and 5 more
Managing Director 29 Mar 2000 26 Years 3 Months Current
Madhukar Dhondiraj Deshpande
Also directs: Nath Industries Limited, Cropflora Genetics Private Limited
Director 10 Feb 2021 5 Years 5 Months Current
Jeevanlata Nandkishor Kagliwal
Also directs: Agri-Tech (India) Limited, Nath Bio-Technologies Limited, Ferry Fax Farms Pvt Ltd and 5 more
Director 30 May 2019 7 Years 1 Months Current
Hitesh Rajnikant Purohit
Also directs: Agri-Tech (India) Limited, Nath Industries Limited, N C F S Limited and 1 more
Director 30 Mar 2022 4 Years 3 Months Current
Vadla Nagabhushanam Director 07 Nov 2020 5 Years 8 Months Current
Payal Dilipkumar Jain Director 11 Jul 2025 1 Years 0 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Nath Bio-Genes (India) Limited FY 2026 filings available

Nath Bio-Genes (India) Limited reported revenue of ₹445.1 Cr (up 21.98% YoY) for FY 2026.

Revenue · FY 2026
₹445.1 Cr ▲ 21.98%
Profit · FY 2026
₹41.63 Cr ▲ 7.85%
Computed EBITDA · FY 2026
₹60.25 Cr ▲ 10.87%
Revenue₹ Cr · Consolidated0200400600FY 2023: ₹301 Cr301FY 2023FY 2024: ₹333 Cr · +10.4% YoY333+10.4%FY 2024FY 2025: ₹365 Cr · +9.7% YoY365+9.7%FY 2025FY 2026: ₹445 Cr · +22% YoY445+22%FY 2026
Net Profit₹ Cr · Consolidated0204060FY 2023: ₹35 Cr35FY 2023FY 2024: ₹40 Cr · +13.1% YoY39.6+13.1%FY 2024FY 2025: ₹39 Cr · -2.6% YoY38.6-2.6%FY 2025FY 2026: ₹42 Cr · +7.9% YoY41.6+7.9%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200300Q1'25: ₹244 Cr · +3.7% YoY244+3.7%Q1'25Q2'25: ₹32 Cr · +42.6% YoY32.2+42.6%Q2'25Q3'25: ₹37 Cr · +16.2% YoY36.9+16.2%Q3'25Q4'25: ₹52 Cr · +20.7% YoY52+20.7%Q4'25Q1'26: ₹284 Cr · +16.3% YoY284+16.3%Q1'26Q2'26: ₹44 Cr · +36.2% YoY43.8+36.2%Q2'26Q3'26: ₹66 Cr · +78.9% YoY66+78.9%Q3'26Q4'26: ₹52 Cr · -0.7% YoY51.6-0.7%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Revenue from Operations ₹445.1 Cr ₹364.91 Cr ₹332.62 Cr ₹301.36 Cr
Other Income ₹7.81 Cr ₹4.55 Cr ₹62.66 Lakh ₹55.35 Lakh
Total Income ₹452.91 Cr ₹369.45 Cr ₹333.25 Cr ₹301.92 Cr
Cost of Materials Consumed ₹306.18 Cr ₹225.54 Cr ₹142.47 Cr ₹117.32 Cr
Purchases of Stock-in-Trade ₹7.7 Cr ₹12.73 Cr ₹12.26 Cr ₹5.31 Cr
Changes in Inventories -₹112.38 Cr -₹102.73 Cr -₹21.16 Cr ₹11.98 Cr
Employee Benefit Expense ₹35.79 Cr ₹32.5 Cr ₹28.25 Cr ₹23.32 Cr
Finance Costs ₹15.99 Cr ₹10.48 Cr ₹9.11 Cr ₹10.12 Cr
Depreciation & Amortisation ₹3.96 Cr ₹3.82 Cr ₹3.26 Cr ₹3.01 Cr
Other Expenses ₹155.37 Cr ₹147.06 Cr ₹120.94 Cr ₹94.69 Cr
Total Expenses ₹412.62 Cr ₹329.41 Cr ₹295.13 Cr ₹265.75 Cr
Profit Before Exceptional Items & Tax ₹40.3 Cr ₹40.04 Cr ₹38.12 Cr ₹36.16 Cr
Exceptional Items ₹6.01 Cr ₹54.03 Lakh ₹3.45 Cr ₹0
Profit Before Tax ₹46.3 Cr ₹40.58 Cr ₹41.57 Cr ₹36.16 Cr
Total Tax Expense ₹4.67 Cr ₹1.98 Cr ₹1.95 Cr ₹1.15 Cr
Net Profit ₹41.63 Cr ₹38.6 Cr ₹39.62 Cr ₹35.03 Cr
  attributable to Owners ₹0 ₹0 ₹0 -
  attributable to NCI ₹0 ₹0 ₹0 -
Other Comprehensive Income -₹1.76 Cr -₹33.05 Lakh ₹92.77 Lakh ₹2.06 Lakh
Total Comprehensive Income ₹39.87 Cr ₹38.27 Cr ₹40.55 Cr ₹35.05 Cr
EBITDA (computed) ₹60.25 Cr ₹54.34 Cr ₹50.49 Cr ₹49.3 Cr
Basic EPS ₹20.98 ₹0.00 ₹21.34 ₹18.42
Diluted EPS ₹20.98 ₹0.00 ₹21.34 ₹18.42
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,097.42 Cr ₹1,026.21 Cr ₹880.23 Cr ₹792.8 Cr
Non-current Assets ₹318.56 Cr ₹336.2 Cr ₹308.57 Cr ₹271.97 Cr
Current Assets ₹778.86 Cr ₹690.01 Cr ₹571.66 Cr ₹520.83 Cr
Property, Plant & Equipment ₹243.8 Cr ₹243.19 Cr ₹240.65 Cr ₹233.96 Cr
Inventories ₹450.55 Cr ₹338.02 Cr ₹230.31 Cr ₹207.85 Cr
Trade Receivables ₹85.41 Cr ₹88.9 Cr ₹94.31 Cr ₹97.31 Cr
Cash & Equivalents ₹76 Cr ₹88.9 Cr ₹77.41 Cr ₹38 Cr
Equity (Net Worth) ₹680.46 Cr ₹644.39 Cr ₹609.92 Cr ₹573.17 Cr
Equity Share Capital ₹19 Cr ₹19 Cr ₹19 Cr ₹19 Cr
Borrowings (Non-current) ₹17.32 Cr ₹12.98 Cr ₹0 ₹40.32 Lakh
Borrowings (Current) ₹121.18 Cr ₹109.52 Cr ₹105.48 Cr ₹104.81 Cr
Total Debt (computed) ₹138.5 Cr ₹122.5 Cr ₹105.48 Cr ₹105.21 Cr
Current Liabilities ₹394.7 Cr ₹365.3 Cr ₹262.45 Cr ₹216.45 Cr
Total Liabilities ₹416.96 Cr ₹381.82 Cr ₹270.31 Cr ₹219.62 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Operating Cash Flow -₹12.57 Cr ₹17.58 Cr ₹70.28 Cr ₹38.37 Cr
Investing Cash Flow ₹3.46 Cr -₹3.96 Cr -₹27.4 Cr -₹2.88 Cr
Financing Cash Flow -₹3.81 Cr -₹2.13 Cr -₹4.51 Cr -₹1.67 Cr
Capital Expenditure ₹3.01 Cr ₹7.92 Cr ₹8.39 Cr ₹2.48 Cr
Free Cash Flow (computed) -₹15.58 Cr ₹9.66 Cr ₹61.89 Cr ₹35.89 Cr
Dividends Paid ₹3.8 Cr ₹3.8 Cr -₹3.8 Cr ₹3.8 Cr
Net Change in Cash -₹12.93 Cr ₹11.49 Cr ₹38.37 Cr ₹33.82 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹51.59 Cr ₹65.96 Cr ₹43.85 Cr ₹283.7 Cr ₹51.97 Cr ₹36.87 Cr ₹32.19 Cr ₹243.88 Cr ₹43.04 Cr ₹31.74 Cr ₹22.57 Cr ₹235.28 Cr
Other Income ₹2.38 Cr ₹1.74 Cr ₹1.93 Cr ₹1.76 Cr ₹3.86 Cr ₹47.82 Lakh ₹7.55 Lakh ₹13.02 Lakh ₹41.07 Lakh ₹3.74 Lakh ₹6.15 Lakh ₹11.7 Lakh
Total Income ₹53.97 Cr ₹67.69 Cr ₹45.78 Cr ₹285.46 Cr ₹55.83 Cr ₹37.35 Cr ₹32.27 Cr ₹244.01 Cr ₹43.45 Cr ₹31.78 Cr ₹22.63 Cr ₹235.4 Cr
Cost of Materials Consumed ₹69.2 Cr ₹106.33 Cr ₹21.8 Cr ₹108.85 Cr ₹101.6 Cr ₹86.87 Cr ₹68.51 Lakh ₹66.39 Cr ₹59.02 Cr ₹8.36 Cr ₹5.66 Cr ₹69.42 Cr
Purchases of Stock-in-Trade ₹2.05 Cr ₹1.02 Cr ₹27.7 Lakh ₹4.35 Cr ₹95.3 Lakh ₹5.21 Cr ₹3.75 Cr ₹2.82 Cr ₹3.71 Cr ₹2.42 Cr ₹4.08 Cr ₹2.07 Cr
Changes in Inventories -₹55.45 Cr -₹78.57 Cr -₹4.97 Cr ₹26.62 Cr -₹84.87 Cr -₹79.59 Cr ₹8.03 Cr ₹53.71 Cr -₹71.79 Cr ₹3.35 Cr -₹5.51 Cr ₹51.29 Cr
Employee Benefit Expense ₹4.21 Cr ₹11.61 Cr ₹10.39 Cr ₹9.59 Cr ₹6.34 Cr ₹10.49 Cr ₹8.94 Cr ₹6.74 Cr ₹7.17 Cr ₹5.99 Cr ₹7.85 Cr ₹7.19 Cr
Finance Costs ₹4.59 Cr ₹4.54 Cr ₹3.66 Cr ₹3.2 Cr ₹1.37 Cr ₹3.9 Cr ₹2.98 Cr ₹2.24 Cr ₹1.07 Cr ₹2.84 Cr ₹2.44 Cr ₹2.76 Cr
Depreciation & Amortisation ₹1.03 Cr ₹97.53 Lakh ₹98.72 Lakh ₹97.5 Lakh ₹1.34 Cr ₹82.5 Lakh ₹82.5 Lakh ₹82.5 Lakh ₹98.12 Lakh ₹76 Lakh ₹76 Lakh ₹76 Lakh
Other Expenses ₹27.11 Cr ₹22 Cr ₹10.25 Cr ₹96 Cr ₹27.53 Cr ₹5.86 Cr ₹5.98 Cr ₹77.69 Cr ₹41 Cr ₹5.97 Cr ₹4.96 Cr ₹68.5 Cr
Total Expenses ₹52.74 Cr ₹67.9 Cr ₹42.39 Cr ₹249.59 Cr ₹54.26 Cr ₹33.56 Cr ₹31.18 Cr ₹210.41 Cr ₹41.16 Cr ₹29.69 Cr ₹20.25 Cr ₹202 Cr
Profit Before Exceptional Items & Tax ₹1.23 Cr -₹20.82 Lakh ₹3.39 Cr ₹35.88 Cr ₹1.57 Cr ₹3.79 Cr ₹1.09 Cr ₹33.6 Cr ₹2.28 Cr ₹2.09 Cr ₹2.38 Cr ₹33.4 Cr
Exceptional Items ₹1.26 Cr ₹2.69 Cr ₹2.06 Cr ₹2.06 Cr ₹54.03 Lakh ₹0 ₹0 ₹0 ₹94.9 Lakh ₹2.5 Cr ₹0 ₹0
Profit Before Tax ₹2.49 Cr ₹2.48 Cr ₹5.46 Cr ₹37.94 Cr ₹2.11 Cr ₹3.79 Cr ₹1.09 Cr ₹33.6 Cr ₹3.23 Cr ₹4.59 Cr ₹2.38 Cr ₹33.4 Cr
Total Tax Expense ₹2.5 Cr ₹87.28 Lakh ₹64.11 Lakh ₹65.97 Lakh ₹62.73 Lakh ₹1.14 Cr -₹2.75 Lakh ₹24.53 Lakh ₹61.51 Lakh ₹76.57 Lakh ₹34.53 Lakh ₹22.01 Lakh
Net Profit -₹92,000 ₹1.61 Cr ₹2.75 Cr ₹37.28 Cr ₹1.48 Cr ₹2.65 Cr ₹1.11 Cr ₹33.35 Cr ₹2.62 Cr ₹3.83 Cr ₹2.07 Cr ₹33.18 Cr
  attributable to Owners ₹0 ₹0 ₹0 ₹0 ₹0 - ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 - ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income -₹1.5 Cr ₹9.15 Lakh -₹8.75 Lakh -₹8 Lakh ₹68.12 Lakh -₹11.69 Lakh -₹10.96 Lakh -₹12.42 Lakh ₹94.27 Lakh ₹56,000 -₹42.55 Lakh ₹0
Total Comprehensive Income -₹1.51 Cr ₹1.7 Cr ₹2.67 Cr ₹37.2 Cr ₹2.16 Cr ₹2.53 Cr ₹1 Cr ₹33.23 Cr ₹3.56 Cr ₹3.84 Cr ₹1.64 Cr ₹33.18 Cr
EBITDA (computed) ₹6.85 Cr ₹5.31 Cr ₹8.04 Cr ₹40.05 Cr ₹4.28 Cr ₹8.51 Cr ₹4.89 Cr ₹36.67 Cr ₹4.34 Cr ₹5.68 Cr ₹5.58 Cr ₹36.93 Cr
Basic EPS ₹-0.79 ₹0.84 ₹1.40 ₹19.58 ₹0.00 ₹1.33 ₹0.53 ₹17.49 ₹1.87 ₹2.02 ₹0.86 ₹17.47
Diluted EPS ₹-0.79 ₹0.84 ₹1.40 ₹19.58 ₹0.00 ₹1.33 ₹0.53 ₹17.49 ₹1.87 ₹2.02 ₹0.86 ₹17.47
Latest 12 quarters shown of 13 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹431.6 Cr ₹362.31 Cr ₹332.62 Cr ₹301.29 Cr ₹278.36 Cr ₹307.56 Cr ₹279.89 Cr
Other Income ₹7.81 Cr ₹4.73 Cr ₹65.34 Lakh ₹56.04 Lakh ₹1.85 Cr ₹1.67 Cr ₹1.82 Cr
Total Income ₹439.41 Cr ₹367.04 Cr ₹333.28 Cr ₹301.85 Cr ₹280.22 Cr ₹309.23 Cr ₹281.71 Cr
Cost of Materials Consumed ₹297.69 Cr ₹217.55 Cr ₹142.45 Cr ₹117.3 Cr ₹115.42 Cr ₹148.9 Cr ₹167.15 Cr
Purchases of Stock-in-Trade ₹7.52 Cr ₹12.51 Cr ₹11.02 Cr ₹5.31 Cr ₹3.56 Cr ₹8.96 Cr ₹7.35 Cr
Changes in Inventories -₹113.89 Cr -₹96.66 Cr -₹19.92 Cr ₹11.98 Cr ₹4.99 Cr -₹21.76 Cr -₹48.25 Cr
Employee Benefit Expense ₹33.33 Cr ₹30.31 Cr ₹27.98 Cr ₹23.23 Cr ₹24.78 Cr ₹23.69 Cr ₹18.74 Cr
Finance Costs ₹13.31 Cr ₹9.65 Cr ₹9.1 Cr ₹10.12 Cr ₹10.61 Cr ₹8.82 Cr ₹6.55 Cr
Depreciation & Amortisation ₹3.95 Cr ₹3.79 Cr ₹3.26 Cr ₹3.01 Cr ₹3.08 Cr ₹2.82 Cr ₹1.45 Cr
Other Expenses ₹154.41 Cr ₹145.76 Cr ₹120.7 Cr ₹94.58 Cr ₹92.37 Cr ₹81.06 Cr ₹80.22 Cr
Total Expenses ₹396.32 Cr ₹322.91 Cr ₹294.6 Cr ₹265.53 Cr ₹254.82 Cr ₹252.48 Cr ₹233.2 Cr
Profit Before Exceptional Items & Tax ₹43.09 Cr ₹44.12 Cr ₹38.67 Cr ₹36.32 Cr ₹25.4 Cr ₹56.75 Cr ₹48.51 Cr
Exceptional Items ₹6.01 Cr ₹0 ₹3.45 Cr ₹0 -₹88.78 Cr ₹0 ₹0
Profit Before Tax ₹49.1 Cr ₹44.12 Cr ₹42.12 Cr ₹36.32 Cr -₹63.39 Cr ₹56.75 Cr ₹48.51 Cr
Total Tax Expense ₹4.67 Cr ₹1.98 Cr ₹1.95 Cr ₹1.15 Cr ₹3.95 Cr ₹1.09 Cr -₹1.98 Cr
Net Profit ₹44.43 Cr ₹42.14 Cr ₹40.18 Cr ₹35.17 Cr -₹67.34 Cr ₹55.66 Cr ₹50.48 Cr
Other Comprehensive Income ₹7.82 Lakh -₹33.04 Lakh ₹92.77 Lakh ₹2.06 Lakh ₹0 ₹0 -₹44.75 Lakh
Total Comprehensive Income ₹44.5 Cr ₹41.81 Cr ₹41.1 Cr ₹35.19 Cr -₹67.34 Cr ₹55.66 Cr ₹50.04 Cr
EBITDA (computed) ₹60.35 Cr ₹57.56 Cr ₹51.04 Cr ₹49.45 Cr ₹39.09 Cr ₹68.39 Cr ₹56.51 Cr
Basic EPS ₹23.42 ₹0.00 ₹21.63 ₹18.50 ₹-35.43 ₹29.29 ₹26.33
Diluted EPS ₹23.42 ₹0.00 ₹21.63 ₹18.50 ₹-35.43 ₹29.29 ₹26.33
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,082.9 Cr ₹1,016.87 Cr ₹877.08 Cr ₹792.97 Cr
Non-current Assets ₹318.7 Cr ₹336.32 Cr ₹308.57 Cr ₹271.98 Cr
Current Assets ₹764.21 Cr ₹680.55 Cr ₹568.52 Cr ₹520.99 Cr
Property, Plant & Equipment ₹243.67 Cr ₹243.04 Cr ₹240.64 Cr ₹233.96 Cr
Inventories ₹444.6 Cr ₹330.71 Cr ₹229.07 Cr ₹207.85 Cr
Trade Receivables ₹83.79 Cr ₹88.84 Cr ₹94.31 Cr ₹97.31 Cr
Cash & Equivalents ₹70.67 Cr ₹87.63 Cr ₹75.5 Cr ₹37.98 Cr
Equity (Net Worth) ₹689.37 Cr ₹648.67 Cr ₹610.66 Cr ₹573.35 Cr
Equity Share Capital ₹19 Cr ₹19 Cr ₹19 Cr ₹19 Cr
Borrowings (Non-current) ₹55.34 Lakh ₹1.61 Cr ₹2.83 Cr ₹40.32 Lakh
Borrowings (Current) ₹121.18 Cr ₹109.52 Cr ₹105.48 Cr ₹104.81 Cr
Total Debt (computed) ₹121.73 Cr ₹111.13 Cr ₹108.31 Cr ₹105.21 Cr
Current Liabilities ₹388.03 Cr ₹363.05 Cr ₹260.6 Cr ₹216.43 Cr
Total Liabilities ₹393.53 Cr ₹368.2 Cr ₹266.42 Cr ₹219.62 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹13.91 Cr ₹26.88 Cr ₹74.72 Cr ₹38.36 Cr ₹17.05 Cr
Investing Cash Flow ₹3.46 Cr -₹4.05 Cr -₹27.4 Cr -₹2.88 Cr -₹19.87 Cr
Financing Cash Flow -₹6.51 Cr -₹10.62 Cr -₹9.81 Cr -₹1.67 Cr -₹22.23 Cr
Capital Expenditure ₹3.01 Cr ₹7.75 Cr ₹26.77 Cr ₹2.48 Cr ₹1.1 Cr
Free Cash Flow (computed) -₹16.92 Cr ₹19.13 Cr ₹47.95 Cr ₹35.88 Cr ₹15.95 Cr
Dividends Paid ₹3.8 Cr ₹3.8 Cr ₹3.8 Cr ₹3.8 Cr ₹3.8 Cr
Net Change in Cash -₹16.96 Cr ₹12.21 Cr ₹37.52 Cr ₹33.81 Cr -₹25.05 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹45.69 Cr ₹65.96 Cr ₹39.77 Cr ₹280.17 Cr ₹49.37 Cr ₹36.87 Cr ₹32.19 Cr ₹243.88 Cr ₹43.04 Cr ₹31.74 Cr ₹22.57 Cr ₹235.28 Cr
Other Income ₹2.38 Cr ₹1.74 Cr ₹1.93 Cr ₹1.76 Cr ₹4.04 Cr ₹47.82 Lakh ₹6.63 Lakh ₹13.94 Lakh ₹43.75 Lakh ₹3.74 Lakh ₹6.15 Lakh ₹11.7 Lakh
Total Income ₹48.07 Cr ₹67.7 Cr ₹41.7 Cr ₹281.94 Cr ₹53.41 Cr ₹37.35 Cr ₹32.26 Cr ₹244.01 Cr ₹43.48 Cr ₹31.78 Cr ₹22.63 Cr ₹235.4 Cr
Cost of Materials Consumed ₹67.7 Cr ₹101.2 Cr ₹20.55 Cr ₹108.24 Cr ₹100.62 Cr ₹84.78 Cr -₹52.27 Lakh ₹62.67 Cr ₹59.02 Cr ₹8.35 Cr ₹5.66 Cr ₹69.42 Cr
Purchases of Stock-in-Trade ₹1.87 Cr ₹1.02 Cr ₹27.7 Lakh ₹4.35 Cr ₹86.05 Lakh ₹5.21 Cr ₹3.75 Cr ₹2.69 Cr ₹2.56 Cr ₹2.41 Cr ₹4.08 Cr ₹1.97 Cr
Changes in Inventories -₹56.62 Cr -₹73.12 Cr -₹7.95 Cr ₹23.8 Cr -₹85.95 Cr -₹77.5 Cr ₹9.24 Cr ₹57.55 Cr -₹50.14 Cr ₹3.37 Cr -₹5.51 Cr ₹51.36 Cr
Employee Benefit Expense ₹3.48 Cr ₹11.14 Cr ₹9.66 Cr ₹9.05 Cr ₹5.51 Cr ₹10.26 Cr ₹8.17 Cr ₹6.37 Cr ₹7.08 Cr ₹5.93 Cr ₹7.85 Cr ₹7.13 Cr
Finance Costs ₹2.94 Cr ₹4.18 Cr ₹3.3 Cr ₹2.89 Cr ₹1.1 Cr ₹3.37 Cr ₹2.94 Cr ₹2.24 Cr ₹1.06 Cr ₹2.84 Cr ₹2.44 Cr ₹2.76 Cr
Depreciation & Amortisation ₹1.02 Cr ₹97.5 Lakh ₹97.5 Lakh ₹97.5 Lakh ₹1.32 Cr ₹82.5 Lakh ₹82.5 Lakh ₹82.5 Lakh ₹98.12 Lakh ₹76 Lakh ₹76 Lakh ₹76 Lakh
Other Expenses ₹22.65 Cr ₹16.88 Cr ₹10.05 Cr ₹95.83 Cr ₹24.62 Cr ₹6.62 Cr ₹5 Cr ₹77.53 Cr ₹20.04 Cr ₹5.9 Cr ₹4.96 Cr ₹68.37 Cr
Total Expenses ₹43.04 Cr ₹62.28 Cr ₹36.86 Cr ₹245.13 Cr ₹48.07 Cr ₹33.56 Cr ₹29.4 Cr ₹209.88 Cr ₹40.6 Cr ₹29.55 Cr ₹20.25 Cr ₹201.78 Cr
Profit Before Exceptional Items & Tax ₹5.03 Cr ₹5.42 Cr ₹4.84 Cr ₹36.8 Cr ₹5.34 Cr ₹3.79 Cr ₹2.86 Cr ₹34.13 Cr ₹2.87 Cr ₹2.22 Cr ₹2.38 Cr ₹33.62 Cr
Exceptional Items ₹1.26 Cr ₹2.69 Cr ₹0 ₹2.06 Cr ₹0 ₹0 ₹0 ₹0 ₹94.9 Lakh ₹2.5 Cr ₹0 ₹0
Profit Before Tax ₹6.29 Cr ₹8.1 Cr ₹4.84 Cr ₹38.87 Cr ₹5.34 Cr ₹3.79 Cr ₹2.86 Cr ₹34.13 Cr ₹3.82 Cr ₹4.72 Cr ₹2.38 Cr ₹33.62 Cr
Total Tax Expense ₹2.5 Cr ₹87.28 Lakh ₹64.11 Lakh ₹65.97 Lakh ₹62.73 Lakh ₹1.14 Cr -₹2.75 Lakh ₹24.53 Lakh ₹61.5 Lakh ₹76.57 Lakh ₹34.53 Lakh ₹22.01 Lakh
Net Profit ₹3.79 Cr ₹7.23 Cr ₹4.2 Cr ₹38.21 Cr ₹4.71 Cr ₹2.66 Cr ₹2.89 Cr ₹33.89 Cr ₹3.21 Cr ₹3.96 Cr ₹2.03 Cr ₹33.4 Cr
Other Comprehensive Income ₹33.72 Lakh ₹9.15 Lakh -₹8.75 Lakh -₹8 Lakh -₹68.11 Lakh -₹11.69 Lakh -₹10.96 Lakh -₹12.42 Lakh ₹94.27 Lakh ₹56,000 -₹42.55 Lakh ₹0
Total Comprehensive Income ₹4.13 Cr ₹7.32 Cr ₹4.11 Cr ₹38.13 Cr ₹4.03 Cr ₹2.54 Cr ₹2.78 Cr ₹33.76 Cr ₹4.15 Cr ₹3.96 Cr ₹1.61 Cr ₹33.4 Cr
EBITDA (computed) ₹8.99 Cr ₹10.57 Cr ₹9.12 Cr ₹40.67 Cr ₹7.75 Cr ₹7.99 Cr ₹6.63 Cr ₹37.2 Cr ₹4.92 Cr ₹5.82 Cr ₹5.58 Cr ₹37.15 Cr
Basic EPS ₹2.17 ₹3.80 ₹2.16 ₹20.06 ₹0.00 ₹1.34 ₹1.46 ₹17.77 ₹2.18 ₹2.09 ₹0.85 ₹17.58
Diluted EPS ₹2.17 ₹3.80 ₹2.16 ₹20.06 ₹0.00 ₹1.34 ₹1.46 ₹17.77 ₹2.18 ₹2.09 ₹0.85 ₹17.58
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Nath Bio-Genes (India) Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Nath Bio-Genes (India) Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 45.60%, foreign institutional investors hold 0.23%, domestic institutional investors hold 0.01%, retail and other public shareholders hold 54.17% of Nath Bio-Genes (India) Limited. The company had 33,031 shareholders on record.

Promoters: 45.60%DII (Domestic Institutional): 0.01%FII (Foreign Institutional): 0.23%Retail & Others: 54.17%
Mar 2026
QUARTER
45.60% Promoters
0.01% DII (Domestic Institutional)
0.23% FII (Foreign Institutional)
54.17% Retail & Others
Promoter holding - history
Now 45.60% · Mar 2026High 51.39% · Mar 2016Low 40.59% · Dec 2018
39%42.5%46%49.5%53%Dec 2015Mar 2018Sep 2020Mar 2023Sep 2025Dec 2015: 45.01%Mar 2016: 51.39%Jun 2016: 51.39%Sep 2016: 51.35%Dec 2016: 51.28%Mar 2017: 51.23%Jun 2017: 48.32%Sep 2017: 48.46%Dec 2017: 48.24%Jan 2018: 40.75%Mar 2018: 40.69%Jun 2018: 40.69%Sep 2018: 40.69%Dec 2018: 40.59%Mar 2019: 40.72%Jun 2019: 40.72%Sep 2019: 40.72%Dec 2019: 40.72%Mar 2020: 41.79%Jun 2020: 41.79%Sep 2020: 41.79%Dec 2020: 41.79%Mar 2021: 40.86%Jun 2021: 41.03%Sep 2021: 41.03%Dec 2021: 41.03%Mar 2022: 41.05%Jun 2022: 41.07%Sep 2022: 45.60%Dec 2022: 45.60%Mar 2023: 45.60%Jun 2023: 45.60%Sep 2023: 45.60%Dec 2023: 45.60%Mar 2024: 45.60%Jun 2024: 45.60%Sep 2024: 45.60%Dec 2024: 45.60%Mar 2025: 45.60%Jun 2025: 45.60%Sep 2025: 45.60%Dec 2025: 45.60%Mar 2026: 45.60%51.39%40.59%45.60%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters45.60%45.60%45.60%45.60%45.60%45.60%
Public54.40%54.40%54.40%54.40%54.40%54.40%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters45.60%45.60%45.60%45.60%41.05%40.86%41.79%40.72%40.69%51.23%51.39%
Public54.40%54.40%54.40%54.40%58.95%59.14%58.21%59.28%59.31%48.77%48.61%
Promoter change (YoY, %pts)+0.00+0.00+0.00+4.55+0.19-0.93+1.07+0.03-10.54-0.16-

Board & Governance of Nath Bio-Genes (India) Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Nath Bio-Genes (India) Limited has 7 directors - 4 independent and 2 executive. The board is chaired by Satish Laxminarayan Kagliwal.

DirectorPositionOn board sinceListed boards
Satish Laxminarayan Kagliwal Executive Director · MD · Chairperson 2000-03-29 3
Jeevanlata Nandkishor Kagliwal Executive Director 2019-05-30 2
Vadla Nagbhushanam Non-Executive - Independent Director 2020-11-07 1
Madhukar Dhondiraj Deshpande Non-Executive - Independent Director 2021-02-10 2
Hitesh Rajnikant Purohit Non-Executive - Independent Director 2022-03-30 3
Akash Kagliwal Non-Executive - Non Independent Director 2023-04-22 3
Payal Dilipkumar Jain Non-Executive - Independent Director 2025-07-11 1
Board Committees
CommitteeMembers
Audit Committee Madhukar Dhondiraj Deshpande (Chairperson), Vadla Nagbhushanam, Satish Laxminarayan Kagliwal
Nomination and remuneration committee Hitesh Rajnikant Purohit (Chairperson), Vadla Nagbhushanam, Madhukar Dhondiraj Deshpande
Stakeholders Relationship Committee Madhukar Dhondiraj Deshpande (Chairperson), Vadla Nagbhushanam, Satish Laxminarayan Kagliwal
Risk Management Committee Satish Laxminarayan Kagliwal (Chairperson), Vadla Nagbhushanam, Hitesh Rajnikant Purohit
Corporate Social Responsibility Committee Vadla Nagbhushanam (Chairperson), Madhukar Dhondiraj Deshpande, Satish Laxminarayan Kagliwal

Charges & Borrowings of Nath Bio-Genes (India) Limited

Open charges
₹114.1 Cr
Satisfied charges
₹183.2 Cr
Breakdown by lending institutions
Axis Bank Limited₹105.40 Cr
Others₹5.80 Cr
Hdfc Bank Limited₹2.90 Cr
Latest charge details
DateLenderAmountStatus
30 Jul 2025 Others ₹5 Cr Open
13 Jun 2025 Others ₹80 Lakh Open
21 Jun 2024 Axis Bank Limited ₹10.25 Lakh Open
03 Apr 2024 Hdfc Bank Limited ₹57.78 Lakh Open
06 Mar 2024 Hdfc Bank Limited ₹64.53 Lakh Open

Total charge records: 21 View all charges

Employees and EPFO Compliance at Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited has a workforce of 417 employees as of Apr 02, 2024.

Employee count
417
Active EPFO establishments
1
Employee growth
-1.18%
Premium access

Employee and EPFO history for Nath Bio-Genes (India) Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Nath Bio-Genes (India) Limited

Premium access

GST registrations and filing compliance for Nath Bio-Genes (India) Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Nath Bio-Genes (India) Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Nath Bio-Genes (India) Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nath Bio-Genes (India) Limited

Premium access

MSME payment history for Nath Bio-Genes (India) Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nath Bio-Genes (India) Limited

Premium access

Corporate group structure for Nath Bio-Genes (India) Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nath Bio-Genes (India) Limited

Premium access

MCA filings and documents for Nath Bio-Genes (India) Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Nath Bio-Genes (India) Limited

Activity
22 Aug 2025
Nath Bio-Genes (India) Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records.
Charges
30 Jul 2025
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101141509 was registered on 30 Jul 2025.
Directors
11 Jul 2025
Payal Dilipkumar Jain was appointed as a Director on 11 Jul 2025 & has been associated with this company since 1 year 10 days.
Charges
13 Jun 2025
A charge with Others amounted to Rs. 0.80 Cr with Charge ID 101139826 was registered on 13 Jun 2025.
Activity
31 Mar 2025
Nath Bio-Genes (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Directors
03 Jan 2025
Amol Arunrao Gupta was appointed as a Cfo on 03 Jan 2025 & has been associated with this company since 1 year 6 months.

Recent News on Nath Bio-Genes (India) Limited

Update on Nath Bio-Genes (India) Limited
12 Apr 2023 · India Ratings and Research

Frequently Asked Questions about Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited is an active public limited company in the agriculture sector based in Aurangabad, Maharashtra, India. It was incorporated on 14 July 1993 (33+ years old) and is registered under CIN L01110MH1993PLC072842. Listed on BSE: 537291 and NSE: NATHBIOGEN. The company has 417 employees.

Nath Bio-Genes (India) Limited reported revenue of ₹445.1 Cr for FY 2026 (up 21.98% YoY) based on consolidated NSE filings.

The current directors of Nath Bio-Genes (India) Limited are:

The primary industry of Nath Bio-Genes (India) Limited is agriculture. The company specifically operates in seed production and distribution. The company is currently active in this sector.

Yes. Nath Bio-Genes (India) Limited is listed on both BSE (code: 537291) and NSE (symbol: NATHBIOGEN).

Nath Bio-Genes (India) Limited can be reached at the registered office: Nath House Nath Road, Aurangabad, Maharashtra, India – 431005, or through the website nathbiogenes.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available